ADORA2A and Huntington disease: A2AR knockout between 12 and 21 weeks of age in the N171-82-Q transgenic model of HD had a deleterious impact on survival, motor coordination, body weight, striatal volume, and enkephalin and neuropeptide messenger RNA (mRNA) levels (Mievis et al., 2011).